AlphaYou
Overview
Smart money at a glance
Filings to Sep 27, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 1 added, 0 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 27- Open
- $34.46
- 52-wk high
- $51.60
- High
- $36.41
- 52-wk low
- $18.08
- Low
- $34.11
- Prev close
- $34.44
- Mkt cap
- $1.80B
- P/E
- 44.4x
- Volume
- 336.6K
- Fwd P/E
- 9.0x
- Beta
- 0.91
- P/S
- 0.5x
- P/B
- 2.1x
- Profit margin
- +1.1%
- Op margin
- +3.5%
- ROE
- +6.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about ASTH filings
Are insiders buying or selling Astrana Health Inc (ASTH) stock?
Neither. Astrana Health Inc (ASTH) insiders filed no open-market purchases or sales in the 90 days to Sep 27, 2026, according to SEC Form 4 filings.
Which members of Congress have traded ASTH recently?
None. No member of Congress disclosed a ASTH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this ASTH smart-money data?
This summary uses filings available on Sep 27, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position.
What funds are doing
Buys/Adds (1)
- FM
FMR LLC
$21.6M
added
Sells/Trims (1)
- FM
FMR LLC
$16.3M
trimmed
How top traders are positioned
No tracked top-trader positions in ASTH right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 29.0% above what analysts expected.
Earnings per share
$0.31 expected
Reports Nov 5, 2026, in 39 days
Financials
Is the business strong?
Richly priced and running thin margins.
- Net margin
- 1.1%
- P/E
- 44.35
- Forward P/E
- 8.97
- Market cap
- $1.8B
Valuation
- P/S0.47
- P/B2.05
Quality
- Operating margin3.5%
- ROE6.9%
- ROA3.8%
Growth
- Beta0.91
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace